Ipsen S.A. (EPA: IPN)
France
· Delayed Price · Currency is EUR 109.70
+1.00 (0.92%)
Aug 30, 2024, 5:35 PM CET
Ipsen Employees
Ipsen had 5,325 employees as of December 31, 2023. The number of employees increased by 253 or 4.99% compared to the previous year.
Employees
5,325
Change (1Y)
253
Growth (1Y)
4.99%
Revenue / Employee
€645,089
Profits / Employee
€127,925
Market Cap
9.06B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| LVMH Moët Hennessy - Louis Vuitton, Société Européenne | 192,287 |
| Hermès International Société en commandite par actions | 22,037 |
| L'Oréal S.A. | 94,605 |
| Schneider Electric S.E. | 168,000 |
| Christian Dior SE | 196,686 |
| EssilorLuxottica Société anonyme | 151,292 |
| L'Air Liquide S.A. | 67,778 |
| AXA SA | 94,705 |
Ipsen News
- 5 weeks ago - Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024) - GlobeNewsWire
- 3 months ago - Annual General Meeting of Ipsen S.A. held on 28 May 2024 - GlobeNewsWire
- 3 months ago - Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at Ipsen S.A.'s Annual General Meeting on 28 May 2024 - GlobeNewsWire
- 4 months ago - Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting - GlobeNewsWire
- 4 months ago - Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance - GlobeNewsWire
- 7 months ago - Ipsen S.A. publishes its 2023 Consolidated Financial Statements - GlobeNewsWire
- 1 year ago - US FDA approves Ipsen's rare bone disorder drug - Reuters
- 1 year ago - US FDA approves Ipsen's SohonosTM (palovarotene) capsules, the first and only treatment for people with fibrodysplasia ossificans progressiva - GlobeNewsWire